MDT vs PODD
Medtronic (MDT) and Insulet (PODD) compared side by side. Medtronic (MDT) is larger, with a market cap of $122.0B versus $10.3B for Insulet, about 11.8 times the size. On trailing earnings, MDT is cheaper at 23.4x versus 27.9x for PODD.
Head to head
| Metric | MDT | PODD |
|---|---|---|
| Market cap | $122.0B | $10.3B |
| P/E (TTM) | 23.4x | 27.9x |
| Forward P/E | 14.9x | 19.3x |
| Revenue (TTM) | $37.5B | $3.1B |
| Revenue growth | 13.7% | 23.5% |
| Gross margin | 65.3% | 71.1% |
| Operating margin | 19.3% | 16.2% |
| Free cash flow | $6.1B | $265.6M |
| Dividend yield | 3.02% | None |
| 1-year return | +4.6% | -53.9% |
| 5-year return (annual) | -1.9% | -13.3% |
| Max drawdown | -73% | -90% |
| FI Handbook grade | B- | B- |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
$5.0K
$7.5K
$10.0K
20222023202420252026
MDT vs PODD FAQ
Which is bigger, MDT or PODD?
Medtronic (MDT) is larger, with a market cap of $122.0B versus $10.3B for Insulet, about 11.8 times the size.
Is MDT or PODD cheaper?
On trailing earnings, MDT is cheaper at 23.4x versus 27.9x for PODD. A lower P/E can reflect slower expected growth, so compare growth and margins too.
Which stock performed better over the past year, MDT or PODD?
MDT returned +4.6% over the past year including dividends, versus -53.9% for PODD, through October 23, 2026.
Which pays a higher dividend, MDT or PODD?
MDT yields 3.02%; PODD does not pay a dividend.